TIRZ5 (5mg)
TIRZ5 is a dual GIP and GLP-1 receptor agonist that addresses metabolic health through two complementary incretin pathways. By mimicking these gut-derived hormones, it improves insulin sensitivity, reduces glucagon output, slows gastric emptying, and suppresses appetite — creating a comprehensive metabolic environment for weight management and glycemic control. Research highlights its effectiveness in both obesity management and broader metabolic optimization.
Product Highlights
Dosing Instructions
Reconstitute with bacteriostatic water as directed. Administer via subcutaneous injection as per your protocol. Begin conservatively and adjust only under appropriate guidance.
Compound Information
Recommended Dose: 2.5mg to 12mg per week.
Frequency: Once per week.
Administration: Subcutaneous Injection.
Molecular Weight: 4813.49 g/mol.
Formula: C225H348N48O68.
Half-Life: 5 days.
Note: All peptide products are for research purposes only. Information provided is educational and not a substitute for medical advice.
Need help with mixing your peptides? Use our peptide mixing calculator below.
Description
Additional information
| Weight | 6 g |
|---|---|
| Dimensions | 3.7 × 1.5 × 1.5 in |
